| Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization | |
| Li, Qing; Wu, Tao; Ma, Xiao-An; Jing, Li; Han, Li-Li; Guo, Hui | |
| 刊名 | THERAPEUTICS AND CLINICAL RISK MANAGEMENT
 |
| 2018 | |
| 卷号 | 14页码:991-998 |
| 关键词 | transarterial chemoembolization prognosis ABO blood group liver cancer overall survival |
| ISSN号 | 1178-203X |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/2914281 |
| 专题 | 西安交通大学 |
| 推荐引用方式 GB/T 7714 | Li, Qing,Wu, Tao,Ma, Xiao-An,et al. Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization[J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT,2018,14:991-998. |
| APA | Li, Qing,Wu, Tao,Ma, Xiao-An,Jing, Li,Han, Li-Li,&Guo, Hui.(2018).Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.THERAPEUTICS AND CLINICAL RISK MANAGEMENT,14,991-998. |
| MLA | Li, Qing,et al."Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization".THERAPEUTICS AND CLINICAL RISK MANAGEMENT 14(2018):991-998. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论